Short Q

Post on 03-Apr-2018

214 views 0 download

Transcript of Short Q

  • 7/28/2019 Short Q

    1/53

    1.To understand the etiology and the

    pathogenesis of HDN ?

    Etiology - Caused by blood type incompatibility between mother and

    fetus.

    Pathogenesis :-

    1. Hemolysis of ABO blood type incompatibility can occurred at first

    fetus.

    2. Hemolysis of Rh blood type incompatibility occurred at second orlater fetus.

  • 7/28/2019 Short Q

    2/53

  • 7/28/2019 Short Q

    3/53

    3. Diagnosis and the treatment of HDN ?

    Diagnosis :-

    1Hemolysis of ABO blood type

    incompatibility:

    The antibody release test result is positive

    usually.

    2

    Hemolysis of Rh blood typeincompatibility

    The direct Coombs test is positive usually.

  • 7/28/2019 Short Q

    4/53

    Treatments:

    Premature treatments :-

    Premature delivery:

    If labor is induced, fetal lung maturity must be determined

    using the lecithin/sphingomyelon (L/S) ratio (thin layer

    chromatography) to avoid respiratory distress syndrome Plasmapheresis :

    For the pregnant mother unsuitable the premature delivery.

    Intrauterine blood transfusion:

    If fetal hydrops or fetal Hb

  • 7/28/2019 Short Q

    5/53

    Neonatal treatments: -

    Phototherapy

    Exchange Transfusions

    Pharmacological agents

    Other treatments : -

    Prevention of hypoglycemia,hypothermia.

    To correct hypoxia,anemia,edema and heart failure.

  • 7/28/2019 Short Q

    6/53

    4. Definition :-

    Billirubin encephalopathy

    Neurologic syndrome resulting from the deposition of

    unconjugated bilirubin in nucleus basalis.

    Main cause due to hemolytic disease.

    Caused by any other disease with unconjugated

    hyperbilirubinemia.

  • 7/28/2019 Short Q

    7/53

    5. Clinical manifestations and diagnosis of

    Bilirubin Encephalopathy ?

    Warning stage: lasts about 12-24hrs.

    Spasm stage: lasts about 12-48hrs.

    Convalescent stage: lasts about 2weeks.

    Sequelae stage

  • 7/28/2019 Short Q

    8/53

    Warning stage of BE

    Lethargy

    Low response

    Sucking weakness

    Weak sucking and moro reflexing

    Vomiting

    Reduced muscle tone

    Severe jaundice

  • 7/28/2019 Short Q

    9/53

    Spasm stage

    Convulsion

    Opisthotonos and fever

    Increased muscle tone

    Apnea

    Stiffly extending his of her arms inward rotation with fists

    clenched or even opisthotonos

  • 7/28/2019 Short Q

    10/53

    Convalescent stage

    Nursing and reaction improvement

    Reduction of seizure frequency

    Opisthotonos gradually disappeared

    Muscle tone gradually recovered

  • 7/28/2019 Short Q

    11/53

    Sequelae stage:BE of tetralogy

    Athetosis

    Limitation of eyes movement

    Hearing impairment

    Enamel dysplasia

  • 7/28/2019 Short Q

    12/53

    6. Therapy of BE ?

    Phototherapy

    Plasma or albumin

    Exchange transfusion

    Enzyme inducer: phenobarbital

    Original diseases treatment

    The other symptomatic treatment

  • 7/28/2019 Short Q

    13/53

    7. How do we avoid the bilirubin

    encephalopathy for HDN infants?

    Declining jaundice quickly is necessary 4 HDN

    infants 2 avoid BE .

    Phototherapy

    Exchange transfusions

  • 7/28/2019 Short Q

    14/53

    8. whats the characteristics of physiologic

    jaundice

    The characteristics of physiologic jaundice : -1Jaundice appears at 2~3 days.

    2Full-term neonates jaundice declines to adult levels

    within 14d. Prematures jaundice usually delays to 3~4 wkof age.

    3Bilirubin level of blood serum < 222~257 mol/L

    4Conjugated bilirubin level of blood < 34 mol/L

    5Bilirubin level of blood serum increases every day

    < 85mol/L.

    6General condition of the baby is well.

  • 7/28/2019 Short Q

    15/53

    9. Whats the characteristics of pathologic

    jaundice?

    The characteristics of pathologic jaundice :-

    1Appear too early

    2Degree too severe3Duration too long

    4Progress too rapid

    5Again appeared after it subsided

  • 7/28/2019 Short Q

    16/53

    10. Treatment of neonatal jaundice ?

    Phototherapy

    Light source : spectral outputs 420 500 nm

    Exchange transfusions : -

    Remove antibody

    Remove bilirubin

    Correct anemia

  • 7/28/2019 Short Q

    17/53

    11. Differences between physiologic jaundice

    and pathologic jaundice ?

    Refer to slide 16- 17.

  • 7/28/2019 Short Q

    18/53

    12. Indications & Complications of

    Phototherapy ?

    Phototherapy : Lipid unconjugated bilirubin water- soluble isomeride- Light source: Spectral outputs 420 to 500nm

    Side effects of phototherapy :

    a. Diarrheab. Fever

    c. Skin rash

    d. Bronze baby syndrome

    (Conjugated bilirubin > 4mg/dl)

    e. Riboflavin reduction

    f. Dehydration and Hypocalcemia

  • 7/28/2019 Short Q

    19/53

    13. Diagnosis test of HDN ?

    Sensitized erythrocytes and blood group

    antibodies determination:

    Coombs test : Red blood cells sensitized.

    Antibody releasing test : Sensitivity test to detect

    sensitized erythrocytes.

    Blood type antibody test in the infant serum.

    Blood type antibody test in the maternal serum.

  • 7/28/2019 Short Q

    20/53

    14. Pathophysiology of Rh ?

    Pathophysiology :-

    Seizures etc.

    Red blood cell breakdown

    Hyperbilirubinemia

    Jaundice

    Kernicterus

    Anemia

    1. Liver

    2. Spleen

    3. Heart, other organs

    4. Hydrops

  • 7/28/2019 Short Q

    21/53

    15. Indications of Exchange Transfusions ?

    Indication of transfusions:

    one of the follows

    a. 20mg/dl (340 mol/L)b. > 4mg/dl,Hgb

  • 7/28/2019 Short Q

    22/53

    16. Causes of neonatal hypoxic ischemic

    encephalopathy ?Causes

  • 7/28/2019 Short Q

    23/53

    17. Pathology & Pathophysiological changes

    of neonatal HIE ?

  • 7/28/2019 Short Q

    24/53

    Pathophysiology

  • 7/28/2019 Short Q

    25/53

    18. Clinical features of neonatal HIE ?

    Muscle tone and deep tendon reflexes

    Behavioral abnormalities

    Neonatal reflexes Apnea and seizures

    Stupor and ventilatory support

    Ocular motion and pupils

    Heart rate and blood pressure

    Outcome

  • 7/28/2019 Short Q

    26/53

    19. Differential diagnosis of neonatal HIE ?

    Methylmalonic Acidemia

    Propionic Acidemia

    Urea cycle defects Zellweger syndrome

    Mitochondrial disorders

    Neuromuscular disorders Brain tumors

    Developmental defects

    Infections

  • 7/28/2019 Short Q

    27/53

    20. Treatment of neonatal HIE ?

    Medical Care : -

    Initial resuscitation and stabilization

    Supportive care: mechanical ventilation

    Perfusion and blood pressure management

    Fluid and electrolytes management

    Hyperthermia management

    Treatment of seizures

    Surgical Care

    Consultations

    Diet

  • 7/28/2019 Short Q

    28/53

    21. Prognosis of neonatal HIE ?

    Lack of spontaneous respiratory effort

    The presence of seizures

    Abnormal neurological findings

    Abnormal EEG background

    Feeding difficulties

    Poor head growth

  • 7/28/2019 Short Q

    29/53

    22. Diagnosis criteria of bacterial

    meningitis ?

    Confirmation of the diagnosis: isolation from the CSF of a specific

    bacteria pathogen by microscopy or a positive culture or rapid

    antigen-detection test of CSF

    Gram-stained smear of CSF: identify the causative organism in

    70-90% of cases

    CSF culture: positive in about 80% of cases. Definitive

    diagnosis, determination of antibiotic sensitivity.

    PCR: amplifies bacteria DNA(H influenzae, N meningitidis)

  • 7/28/2019 Short Q

    30/53

    23.Symptom of purulent meningitis ?

    Fever

    Headache

    Vomiting

    Increased ICP

    Meningeal Irritation

    Anorexia

    Malaise

  • 7/28/2019 Short Q

    31/53

  • 7/28/2019 Short Q

    32/53

    25. Treatment of Meningitis

    Antibiotic : Penicilln,Ampicillin,ceftriaxoneCorticosteroid : Dexamethasone

    Mannitol

    General and supportive measure

    Maintenance fluid and thermal energy supplement.

    Fluid administration: 60-80ml/kg.d

  • 7/28/2019 Short Q

    33/53

    26.Complication of epilepsy ?

    1.Mental retardation

    2.Loss of hearing

    3.Impairment of visual area

    4.Motor and sensory deficits

    27 T b l M i i i

  • 7/28/2019 Short Q

    34/53

    27. Tuberculous Meningitis

    (Manifestation)

    Increased Intracranial Pressure

    Cranial Nerve Injury

    Meninges Irritation Signs

    Cerebral-Parenchyma Damage

    Spinal Cord Damage

  • 7/28/2019 Short Q

    35/53

    Pneumonia (Manifestation)

    Tachypnea, Dyspnea,

    Retractions,

    Grunting,

    Nasal flaring,

    Cyanosis and the presence of rales or rhonchi on physical examination.

    Lethargy,

    Poor feeding,

    Fever, temperature instability,

    Apnea,

    Tachycardia,

    Poor perfusion,

    Metabolic acidosis

  • 7/28/2019 Short Q

    36/53

    Tuberculosis Symptoms

    Perpetual Cough

    Fever

    Weight loss

    Night sweats

    Loss of appetite

    Fatigue

    Pain while breathing

  • 7/28/2019 Short Q

    37/53

    Diagnosis of TB

    Tuberculin skin test

    Chest X-ray

    Physical examination

    Serological (blood) test

    AFD test (collect sputum to smear and culture

    it)

  • 7/28/2019 Short Q

    38/53

    TREATMENT FOR ACTIVE TB

    A combination of the following four antibiotics are the mostcommonly used, however are not risk free:

    rifampicin R

    It may cause fever, rashes, liver damage, and in some rare cases has

    led to death.

    isoniazid H It may cause rash and abnormal liver function tests.

    ethambutol E

    It may cause Red-green color blindness and loss of vision

    pyrazinamide Z

    It may cause joint pains, nausea, vomiting, skin rash,, malaise, and

    fever

    When taking antibiotics, overdose and underdose is a problem

  • 7/28/2019 Short Q

    39/53

    Treatment for TB meningitis

    Antituberculosis drugs

    Corticosteroids

    Decrease intracranial pressure

    Ventriculoperitoneal shunting

  • 7/28/2019 Short Q

    40/53

    Questions

    What is diagnostic criteria of nephrotic syndrome?

    How to distinguish the differences between simple type and

    nephritic type?

    What are causes of the nephrotic syndrome ?

    What is histology of primary nephrotic syndrome?

    What are major complications of nephrotic syndrome?

    How to treat nephrotic syndrome?

  • 7/28/2019 Short Q

    41/53

    Diagnostic Criteria

    1. Nephrotic range proteinuria proteinuria(>50mg/kg/day)

    Urine protein 3+ or 4+ by dipstick testing

    2. Hypoalbuminaemia

    serum albumin less than 25g/l

    3. Oedema

    The onset is insidious , with swelling around the eye and facial

    puffiness .Over the next few days ,it gradually increases to involve

    the extremities and abdomen

    4. Hyperlipidemia

    Serum cholesterol more than 5.7mmol/l

  • 7/28/2019 Short Q

    42/53

    Difference

    1. Nephrotic syndrome is a disease of the kidney whilenephritic syndrome is a disease of the glomeruli. Nephriticsyndrome is also called glomerulonephritis.

    2. Nephrotic syndrome manifests the classic symptoms, suchas: edema, proteinuria, hypoalbuminemia, andhyperlipidemia. Nephritic syndrome manifests the sameexcept there is an accompanying blood in the urine.

    3. Diagnosis for nephrotic syndrome is a 24-hoururine/protein measurement and lipid profile while anephritic syndrome involves an ASOT, urine tests, andblood tests.

  • 7/28/2019 Short Q

    43/53

    Main causes of nephrotic syndrome (NS) in children

    Primary nephrotic syndrome

    Secondary nephrotic syndrome (Multisystem diseases )

    Henoch-schonlein purpura Systemic lupus erythematosus Hepatitis B

    Congenital nephrotic syndrome

    Idiopathic CNS of Finnish type Diffuse mesangial sclerosis

    Secondary Congenital syphilis

    Toxoplasmosis Cytomegalovirus

  • 7/28/2019 Short Q

    44/53

    Histopathologic classification

    Minimal change diseases (MCD)

    Pure minimal change diseases

    MCD with mesangial proliferation (MesPGN)

    Focal segmental glomerulosclerosis(FSGS)

    Membranoproliferative glomerulonephritis(MPGN)

    Membraneous nephropathy(MN)

  • 7/28/2019 Short Q

    45/53

    Major Complications of Nephrotic Syndrome

    Infection

    Hypovolaemia

    Thrombosis

    Hyperlipidaemia

    Acute renal failure

    Side-effects of drugs

    Corticosteroids

    Alkylating agents

    Cyclosporin A

  • 7/28/2019 Short Q

    46/53

    Management

    Cyclophosphamide (CTX) CTX2-3mg/kg/day po for 8-12weeks ,or iv pulse CTX 0.5/m2

    Cyclosporine (CsA)

    Dosage of 5-6mg/kg/day to maintain the whole blood trough level

    at 80 to 120ng/ml

    Tacrolimus (FK506)

    0.1mg/kg/day in BD doses

    Trough level maintain at 5-10mcg/l

    Mycophnolate mofetil (MMF)

    Dosage 250-1200mg/m2/day in 2 doses

  • 7/28/2019 Short Q

    47/53

    Supportive Therapy

    To minimize infection(vaccination and prophylactic antibioticcs )

    To minimize risk of thrombosis

    ( hydration; and avoiding prolonged immobilisation)

    To maintain nutrition ( high biological value protein intake ) To treat edema and hypertension

    To treat hypercholesterolaemia (low cholesterol diet and lipidlowering agents)

    To reduce proteinuria (ACEI or angiotensin 2 receptor blockers)

    To avoid the use of nephrotoxic drugs

  • 7/28/2019 Short Q

    48/53

    General Symptoms Acute

    Glomerulonephritis

    Fatigue

    Abdominal pain: more than half

    Low-grade fever

    Loss of appetite Nausea

    Vomiting

    Headache

    Hematuria

    Proteinuria

    Edema Hypertension

  • 7/28/2019 Short Q

    49/53

    Lab Investigation A.G.

    Urinalysis

    Blood test

    Blood Chemistry

    Serological testing

    Complement level (C3,C4)

    Renal Ultrasound

  • 7/28/2019 Short Q

    50/53

    Treatment AG

    Restriction

    Salt

    Fluid intake

    Control of hypertension

    Diuretics (Furosemide)

    Anti hypertensives

    Dialysis

  • 7/28/2019 Short Q

    51/53

    1.Inadequate storage: Premature

  • 7/28/2019 Short Q

    52/53

    Anemia three types:

    Anemia of inadequate production

    Hemolytic anemia

    Blood loss

  • 7/28/2019 Short Q

    53/53

    1.blood filmhypochromic and microcytic2.bone marrow samplingThe bone marrow is hypercellular, with erythroid

    hyperplasia,The normoblasts.may have scanty, fragmented cytoplasm with

    poor hemoglobinization.

    3.iron metabolism:

    Iron study ID IDE IDA*serum ferritin(SF) (